Novo Nordisk – The Hourly News

Headlines

A blood donation session in progress, with a donor lying on a reclining chair.

Hackers Reset French Blood Plasma Freezers from −30°C to 110°C, Health Ministry Says

9 minutes ago9 minutes ago

Official portrait of Josh Turek, Iowa senator-elect, in 2023.

Democrat Josh Turek Flips Iowa Senate Seat in Night of Democratic Gains

43 minutes ago43 minutes ago

An illustration of NASA's Neil Gehrels Swift Observatory in orbit, with its solar panels extended.

NASA’s Swift Telescope Heads for Fiery Re-Entry After 22 Years in Orbit

1 hour ago1 hour ago

A blood sample being examined in a laboratory.

England Launches World-First Trial of GP Blood Tests to Catch Cancer Earlier

1 hour ago1 hour ago

Portrait of Abdul El-Sayed, the Democratic senator-elect from Michigan.

Abdul El-Sayed Wins Michigan Senate Race to Become First Muslim US Senator

2 hours ago2 hours ago

Novo Nordisk headquarters building in Bagsværd, Denmark.

Novo Nordisk Raises Full-Year Outlook for Third Time as Wegovy Pill Beats Forecasts

3 hours ago3 hours ago

The Sveriges Riksbank headquarters at Brunkebergstorg in Stockholm.

Sweden’s Central Bank Raises Rates to 2% for First Time in Over Three Years

3 hours ago

Entrance to the Reserve Bank of India building in Mumbai.

India’s Rupee Set to Resume Slide as Foreign Inflows Stay Weak, Reuters Poll Finds

4 hours ago4 hours ago

The ornate interior of The Metropolitan Bar, a Wetherspoon pub above Baker Street station in London.

Wetherspoon Plans Up to 25 New Pubs as Sales Rise 8.2% in Strong Start to Year

4 hours ago4 hours ago

Ferries and port buildings at Dover, the cross-Channel port through which much UK-EU food trade passes.

UK and EU Agree Draft Deal to Scrap Post-Brexit Food Export Checks

5 hours ago5 hours ago

Novo Nordisk Raises Full-Year Outlook for Third Time as Wegovy Pill Beats Forecasts

Editorial Desk3 hours ago3 hours ago03 mins

Novo Nordisk has raised its full-year outlook for the third time this year after sales of its Wegovy weight-loss pill beat forecasts, in a boost to its fight to win back ground from rival Eli Lilly.

Read Full News